Related Experiment Video
Updated: Aug 26, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Bioavailability prediction based on molecular structure for a diverse series of drugs
Joseph V Turner1, Desmond J Maddalena, Snezana Agatonovic-Kustrin
1Faculty of Pharmacy, The University of Sydney, Sydney NSW 2006 Australia. s4050159@student.uq.edu.au
Purpose:
Radial basis function artificial neural networks and theoretical descriptors were used to develop a quantitative structure-pharmacokinetic relationship for structurally diverse drug compounds.
Methods:
Human bioavailability values were taken from the literature and descriptors were generated from the drug structures. All models were trained with 137 compounds and tested with a further 15, after which they were evaluated for predictive ability with an additional 15 compounds.
Results:
The final model possessed a 10-31-1 topology and training and testing correlation coefficients were 0.736 and 0.897, respectively. Predictions for independent compounds agreed well with experimental literature values, especially for compounds that were well absorbed and/or had high observed bioavailability. Important theoretical descriptors included solubility parameters, electronic descriptors, and topological indices.
Conclusions:
Useful information regarding drug bioavailability was gained from drug structure alone, reducing the need for experimental methods in drug development.
Related Concept Videos
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Modified-Release Drug Delivery Systems: Bioavailability
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Bioavailability: Influencing Factors
Bioavailability: Overview
Bioavailability: Overview
